The genes expressed - turned on, off, up or down - in any given cell determine its type and function. When the wrong genes are expressed at the wrong time or in the wrong amounts, it can lead to disease. At Syros, we are redefining the power of small molecules to control the expression of genes, and in doing so, we aim to make a profound difference in the lives of patients and their families.
Join us in understanding the coordinated expression of the Syros team in fulfilling our mission. We are advancing a growing pipeline of small-molecule medicines that control the expression of genes to treat cancer and genetic diseases. Our pipeline includes three investigational medicines in clinical development and multiple programs in preclinical development and discovery research.
Join us in understanding the coordinated expression of the Syros team in fulfilling our mission. We are advancing a growing pipeline of small-molecule medicines that control the expression of genes to treat cancer and genetic diseases. Our pipeline includes three investigational medicines in clinical development and multiple programs in preclinical development and discovery research.
Services
At Syros, our strength lies in the coordinated expression of our team. We are collaborative to our core and driven to take on big challenges in our shared pursuit of big breakthroughs. Motivated by a purpose greater than ourselves, we are rigorous in our science, harnessing the power of our multiple disciplines and challenging each other to achieve greater heights.
We are committed to fostering an environment where all employees, regardless of race, gender, sexual orientation, religion, ethnicity, national origin, physical disability or age, are empowered to achieve their full potential.
The unique talents, backgrounds and perspectives of each employee strengthens our coordinated expression, making our company stronger and helping us to achieve our mission of developing medicines to transform patients' lives.We believe that diversity in all aspects of business operations will optimize the continued growth and success of our company and the biotechnology industry.
The unique talents, backgrounds and perspectives of each employee strengthens our coordinated expression, making our company stronger and helping us to achieve our mission of developing medicines to transform patients' lives.We believe that diversity in all aspects of business operations will optimize the continued growth and success of our company and the biotechnology industry.
Modern biotechnology is a young industry. But in just a few decades, the entrepreneurs, scientists, researchers and investors working in this field have firmly established themselves at the forefront of medical innovation. Their work is transforming the way we treat - and now even cure - patients with a wide range of once-devastating diseases.
Our leadership team has deep experience in drug discovery, development and commercialization and a proven record of translating innovative science into important therapies. Our company is guided by a distinguished board of industry leaders, world-renowned scientists and seasoned life science investors and entrepreneurs.
Nancy is the founding CEO of Syros and has an established track record of value creation in biotechnology. Prior to Syros, she was Chief Medical Officer at Millennium Pharmaceuticals, and previously, Vice President of Clinical Development at Biogen. Nancy has overseen the successful development of numerous medicines.
Reviews
Be the first to review Syros Pharmaceuticals.
Write a Review
